AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elekta

Share Issue/Capital Change May 2, 2012

2906_rns_2012-05-02_f29495eb-4051-4472-811d-d4afeb1a6162.pdf

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, HONG KONG OR AUSTRALIA

Elekta's rights issue of convertible bonds with preferential rights for the company's shareholders fully subscribed

Press release Stockholm, Sweden, May 2, 2012

In Elekta's rights issue of convertible bonds, 92,845,798 convertible bonds, representing 98.0% percent of the offered convertibles, were subscribed for with primary preferential rights by the exercise of subscription rights. Additionally, 39,447,144 convertible bonds were subscribed for with subsidiary preferential rights and 44,274,388 convertible bonds were subscribed for without preferential rights. Through the rights issue Elekta will receive proceeds amounting to approximately SEK 1,894 M before transaction costs. At full conversion, the number of shares of Series A will increase by 182,692 and the number of shares of Series B will increase by 4,674,983 corresponding to a total dilution of the company's share capital of approximately 4.9 percent.

Those who have subscribed for convertibles with subsidiary preferential rights have been allotted convertibles according to the principles outlined in the prospectus. No convertibles will be allotted to subscriptions without preferential rights. Settlement notes will be sent out on or around May 3, 2012 to subscribers who have been allotted convertible bonds. Payment of allotted convertible bonds shall be made in accordance with the instruction on the settlement note and be paid in cash no later than the third banking day after notification of allotment has been received by the subscriber. The convertible bonds will be delivered as soon as possible after the settlement day with notice from Euroclear Sweden. Only those who have been allotted convertible bonds will be notified.

The final day for trading in paid subscribed convertibles (BTUs) is expected to be on May 4, 2012. Note that there will be no trading in BTUs or convertible bonds on May 7, 2012 in order to effect the conversion of BTUs into convertible bonds. The convertible bonds are expected to be registered with the Swedish Companies Registration Office on May 8, 2012 and to start trading on NASDAQ OMX Stockholm on May 8, 2012.

Financial and legal advisors

SEB Enskilda is acting as financial advisor to Elekta and Deutsche Bank and SEB Enskilda are acting as Joint Bookrunners. Hannes Snellman is acting as legal advisor to Elekta.

For further information, please contact:

Håkan Bergström, CFO, Elekta AB (publ) Tel: +46 (0)8 587 25 547, email: [email protected]

Johan Andersson Melbi, Investor Relations Manager, Elekta AB (publ) Tel: +46 (0) 702 100 451, email: [email protected]

NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, HONG KONG OR AUSTRALIA

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 08:45 CET on May 2, 2012.

******

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

IMPORTANT NOTICE

These materials are not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended (the "Securities Act"). The securities to which these materials relate have not been and will not be registered under the Securities Act and there will be no public offering of the securities in the United States.

No offer or invitation to acquire securities of Elekta AB (publ) is being made by or in connection with this release. Any such offer will be made solely by means of the prospectus that Elekta AB (publ) will prepare: (i) once it has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) in accordance with the Swedish Financial Instruments Trading Act and the Directive 2003/71/EC; and (ii) published in accordance with Swedish law, together with its English translation, (each as supplemented or amended), to, in each case, the persons entitled to receive and rely upon such documents in accordance with their respective terms.

This communication is directed in the United Kingdom solely to persons who: (i) have professional experience in matters relating to investments and who fall within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) are high net worth entities falling within Article 49(2)(a) to (d) of the Order and other persons to whom such communication may otherwise lawfully be made (all such persons together being referred to as the "Relevant Persons"). This communication must not be acted on or relied on by persons who are not the Relevant Persons. Any investment or investment activity to which this communication relates is available only to the Relevant Persons and will be engaged in only with the Relevant Persons. Persons distributing this communication must satisfy themselves that it is lawful to do so.

Deutsche Bank AG is authorised under German Banking Law (competent authority: BaFin – Federal Financial Supervisory Authority) and authorised and subject to limited regulation by the Financial Services Authority. Details about the extent of Deutsche Bank AG's authorisation and regulation by the Financial Services Authority are available on request.

Talk to a Data Expert

Have a question? We'll get back to you promptly.